Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study

BACKGROUND: Vancomycin-resistant enterococcus (VRE) was the fastest growing pathogen in Europe in 2022 (+ 21%) but its clinical relevance is still unclear. We aim to identify risk factors for acquired VRE rectal colonization in hematological patients and evaluate the clinical impact of VRE colonizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Meschiari, Marianna, Kaleci, Shaniko, Monte, Martina Del, Dessilani, Andrea, Santoro, Antonella, Scialpi, Francesco, Franceschini, Erica, Orlando, Gabriella, Cervo, Adriana, Monica, Morselli, Forghieri, Fabio, Venturelli, Claudia, Ricchizzi, Enrico, Chester, Johanna, Sarti, Mario, Guaraldi, Giovanni, Luppi, Mario, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644555/
https://www.ncbi.nlm.nih.gov/pubmed/37957773
http://dx.doi.org/10.1186/s13756-023-01332-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644555/
https://www.ncbi.nlm.nih.gov/pubmed/37957773
http://dx.doi.org/10.1186/s13756-023-01332-x

Ejemplares similares